Here are three devicemaker acquisitions posed to benefit heart patients.
- Irvine, Calif.-based Edwards Lifesciences Corp. announced plans in November to purchase Israel-based Valtech Cardio for $690 million. Through the deal, Edwards Lifesciences will expand its services in heart valve repair and replacement.
2. Minneapolis-based Medtronic acquired HeartWare International for about $1.1 billion in August. Framingham, Mass.-based HeartWare produces miniature implantable heart pumps for patients suffering from advanced heart failure.
3. In December, Wayne, Penn.-based Teleflex purchased Vascular Solutions for about $1 billion. Minneapolis-based Vascular Solutions creates catheters designed to improve vascular procedures.
More articles on supply chain:
AbbVie CEO pledges to rein in price hikes
National Cancer Institute unveils ambitious program to hasten drug research
Op-ed: The 1 way pharma can get on Trump’s good side
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit